WASHINGTON, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Society for Science (the Society) today announced the top 300 scholars in the Regeneron Science Talent Search 2026, the nation’s oldest and most ...
The biotech is developing drugs that target the biology of aging to treat obesity, cardiovascular disease, and more ...
BUFFALO, N.Y. — Five University at Buffalo researchers are participating in a $17 million multi-institution study funded by the National Institute of Dental and Craniofacial Research (NIDCR), part of ...
ELF3 axis enables luminal progenitor transformation in BRCA1-deficient breast cancer by reducing genomic instability and promoting progenitor identity.